Commentary

Podcast

Patient-Centered Treatment Strategies in the Management of nAMD and DME

Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics

Thanks for your interest in this podcast. Please read this important program information before listening.

Episode Description

Recently approved anti-VEGF agents that target additional pathways and offer innovative delivery methods with longer-lasting effects may provide advantages over older anti-VEGF agents in managing patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). In this podcast, expert faculty discuss the roles of ophthalmologists and optometrists in managing nAMD and DME in an evolving treatment landscape, from screening and diagnosis to referral and ongoing patient care.

Acknowledgment of Educational Grant Support

This activity is supported by an educational grant from Genentech, a member of the Roche Group.

Faculty:

Adrienne W. Scott, MD, FASRS

Frederick M. Leader Professor of Ophthalmology
Associate Professor of Ophthalmology, Retina Division
Wilmer Eye Institute
Johns Hopkins University School of Medicine
Baltimore, MD

Disclosure: Grant/Research Support: Genentech/Roche; Consultant: Apellis, EyePoint, Genentech/Roche, Iveric Bio, Regeneron; Honorarium: Allergan/AbbVie, Regeneron; Material Support: Optos.

Justine Cheng, MD

Assistant Professor
Department of Ophthalmology and Vision Sciences
University of Illinois College of Medicine
Chicago, IL

DisclosureJustine Cheng, MD, has no relevant financial relationships with ineligible companies.

Hong-Uyen Hua, MD

Assistant Professor of Clinical Ophthalmology
Bascom Palmer Eye Institute
University of Miami Health System
Miami, FL

Disclosure: Adviser: AbbVie, Alcon, Alimera Sciences/ANI Pharmaceuticals, Genentech.

Sherrol A. Reynolds, OD, FAAO, FNAP

Professor of Optometry
Nova Southeastern University
College of Optometry
Fort Lauderdale, FL

Disclosure: Honorarium: American Diabetes Association, Genentech, Regeneron, Vision Service Plan (VSP).

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.

PER® mitigated all conflict of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Release Date

May 30, 2025

Expiration Date

May 30, 2026

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.